Global Intravenous(IV) Therapy and Vein Access Market 2024 by Company, Regions, Type and Application, Forecast to 2030
![](/report_cover/9988/global-intravenousiv-therapy-n-vein-access-market-2022-by-company-regions-type-n-application-forecast-to-2028_en.gif)
According to our (Global Info Research) latest study, the global Intravenous(IV) Therapy and Vein Access market size was valued at USD 36700 million in 2023 and is forecast to a readjusted size of USD 45920 million by 2030 with a CAGR of 3.3% during review period.
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Intravenous(IV) Therapy and Vein Access industry chain, the market status of Hospital (Infusion Pumps, Implantable Ports), Clinics (Infusion Pumps, Implantable Ports), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravenous(IV) Therapy and Vein Access.
Regionally, the report analyzes the Intravenous(IV) Therapy and Vein Access markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravenous(IV) Therapy and Vein Access market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravenous(IV) Therapy and Vein Access market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravenous(IV) Therapy and Vein Access industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Infusion Pumps, Implantable Ports).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravenous(IV) Therapy and Vein Access market.
Regional Analysis: The report involves examining the Intravenous(IV) Therapy and Vein Access market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravenous(IV) Therapy and Vein Access market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravenous(IV) Therapy and Vein Access:
Company Analysis: Report covers individual Intravenous(IV) Therapy and Vein Access players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravenous(IV) Therapy and Vein Access This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinics).
Technology Analysis: Report covers specific technologies relevant to Intravenous(IV) Therapy and Vein Access. It assesses the current state, advancements, and potential future developments in Intravenous(IV) Therapy and Vein Access areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravenous(IV) Therapy and Vein Access market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravenous(IV) Therapy and Vein Access market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Intravenous(IV) Therapy and Vein Access product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Intravenous(IV) Therapy and Vein Access, with revenue, gross margin and global market share of Intravenous(IV) Therapy and Vein Access from 2019 to 2024.
Chapter 3, the Intravenous(IV) Therapy and Vein Access competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Intravenous(IV) Therapy and Vein Access market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravenous(IV) Therapy and Vein Access.
Chapter 13, to describe Intravenous(IV) Therapy and Vein Access research findings and conclusion.
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Intravenous(IV) Therapy and Vein Access industry chain, the market status of Hospital (Infusion Pumps, Implantable Ports), Clinics (Infusion Pumps, Implantable Ports), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Intravenous(IV) Therapy and Vein Access.
Regionally, the report analyzes the Intravenous(IV) Therapy and Vein Access markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Intravenous(IV) Therapy and Vein Access market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Intravenous(IV) Therapy and Vein Access market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Intravenous(IV) Therapy and Vein Access industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Infusion Pumps, Implantable Ports).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Intravenous(IV) Therapy and Vein Access market.
Regional Analysis: The report involves examining the Intravenous(IV) Therapy and Vein Access market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Intravenous(IV) Therapy and Vein Access market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Intravenous(IV) Therapy and Vein Access:
Company Analysis: Report covers individual Intravenous(IV) Therapy and Vein Access players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Intravenous(IV) Therapy and Vein Access This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinics).
Technology Analysis: Report covers specific technologies relevant to Intravenous(IV) Therapy and Vein Access. It assesses the current state, advancements, and potential future developments in Intravenous(IV) Therapy and Vein Access areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Intravenous(IV) Therapy and Vein Access market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Intravenous(IV) Therapy and Vein Access market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Infusion Pumps
- Implantable Ports
- Intravenous Catheters
- Hypodermic Needles
- Other
- Hospital
- Clinics
- Other
- B. Braun
- Baxter International
- Becton Dickinson
- C. R. Bard
- Fresenius Kabi
- Hospira(ICU Medical)
- Medtronic
- Smiths Group
- Teleflex
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Intravenous(IV) Therapy and Vein Access product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Intravenous(IV) Therapy and Vein Access, with revenue, gross margin and global market share of Intravenous(IV) Therapy and Vein Access from 2019 to 2024.
Chapter 3, the Intravenous(IV) Therapy and Vein Access competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Intravenous(IV) Therapy and Vein Access market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intravenous(IV) Therapy and Vein Access.
Chapter 13, to describe Intravenous(IV) Therapy and Vein Access research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Intravenous(IV) Therapy and Vein Access
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Intravenous(IV) Therapy and Vein Access by Type
1.3.1 Overview: Global Intravenous(IV) Therapy and Vein Access Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type in 2023
1.3.3 Infusion Pumps
1.3.4 Implantable Ports
1.3.5 Intravenous Catheters
1.3.6 Hypodermic Needles
1.3.7 Other
1.4 Global Intravenous(IV) Therapy and Vein Access Market by Application
1.4.1 Overview: Global Intravenous(IV) Therapy and Vein Access Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Other
1.5 Global Intravenous(IV) Therapy and Vein Access Market Size & Forecast
1.6 Global Intravenous(IV) Therapy and Vein Access Market Size and Forecast by Region
1.6.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Intravenous(IV) Therapy and Vein Access Market Size by Region, (2019-2030)
1.6.3 North America Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
1.6.4 Europe Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
1.6.6 South America Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 B. Braun
2.1.1 B. Braun Details
2.1.2 B. Braun Major Business
2.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Product and Solutions
2.1.4 B. Braun Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 B. Braun Recent Developments and Future Plans
2.2 Baxter International
2.2.1 Baxter International Details
2.2.2 Baxter International Major Business
2.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Product and Solutions
2.2.4 Baxter International Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Baxter International Recent Developments and Future Plans
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business
2.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Product and Solutions
2.3.4 Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Becton Dickinson Recent Developments and Future Plans
2.4 C. R. Bard
2.4.1 C. R. Bard Details
2.4.2 C. R. Bard Major Business
2.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Product and Solutions
2.4.4 C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 C. R. Bard Recent Developments and Future Plans
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business
2.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Product and Solutions
2.5.4 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fresenius Kabi Recent Developments and Future Plans
2.6 Hospira(ICU Medical)
2.6.1 Hospira(ICU Medical) Details
2.6.2 Hospira(ICU Medical) Major Business
2.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Product and Solutions
2.6.4 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hospira(ICU Medical) Recent Developments and Future Plans
2.7 Medtronic
2.7.1 Medtronic Details
2.7.2 Medtronic Major Business
2.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Product and Solutions
2.7.4 Medtronic Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Medtronic Recent Developments and Future Plans
2.8 Smiths Group
2.8.1 Smiths Group Details
2.8.2 Smiths Group Major Business
2.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Product and Solutions
2.8.4 Smiths Group Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Smiths Group Recent Developments and Future Plans
2.9 Teleflex
2.9.1 Teleflex Details
2.9.2 Teleflex Major Business
2.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Product and Solutions
2.9.4 Teleflex Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teleflex Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Intravenous(IV) Therapy and Vein Access Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Intravenous(IV) Therapy and Vein Access by Company Revenue
3.2.2 Top 3 Intravenous(IV) Therapy and Vein Access Players Market Share in 2023
3.2.3 Top 6 Intravenous(IV) Therapy and Vein Access Players Market Share in 2023
3.3 Intravenous(IV) Therapy and Vein Access Market: Overall Company Footprint Analysis
3.3.1 Intravenous(IV) Therapy and Vein Access Market: Region Footprint
3.3.2 Intravenous(IV) Therapy and Vein Access Market: Company Product Type Footprint
3.3.3 Intravenous(IV) Therapy and Vein Access Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Intravenous(IV) Therapy and Vein Access Consumption Value and Market Share by Type (2019-2024)
4.2 Global Intravenous(IV) Therapy and Vein Access Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2024)
5.2 Global Intravenous(IV) Therapy and Vein Access Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
6.2 North America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
6.3 North America Intravenous(IV) Therapy and Vein Access Market Size by Country
6.3.1 North America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2030)
6.3.2 United States Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
6.3.3 Canada Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
6.3.4 Mexico Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
7.2 Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
7.3 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country
7.3.1 Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2030)
7.3.2 Germany Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7.3.3 France Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7.3.5 Russia Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7.3.6 Italy Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region
8.3.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2019-2030)
8.3.2 China Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.3 Japan Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.4 South Korea Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.5 India Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.7 Australia Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
9.2 South America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
9.3 South America Intravenous(IV) Therapy and Vein Access Market Size by Country
9.3.1 South America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2030)
9.3.2 Brazil Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
9.3.3 Argentina Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country
10.3.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2030)
10.3.2 Turkey Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
10.3.4 UAE Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Intravenous(IV) Therapy and Vein Access Market Drivers
11.2 Intravenous(IV) Therapy and Vein Access Market Restraints
11.3 Intravenous(IV) Therapy and Vein Access Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Intravenous(IV) Therapy and Vein Access Industry Chain
12.2 Intravenous(IV) Therapy and Vein Access Upstream Analysis
12.3 Intravenous(IV) Therapy and Vein Access Midstream Analysis
12.4 Intravenous(IV) Therapy and Vein Access Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Intravenous(IV) Therapy and Vein Access
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Intravenous(IV) Therapy and Vein Access by Type
1.3.1 Overview: Global Intravenous(IV) Therapy and Vein Access Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type in 2023
1.3.3 Infusion Pumps
1.3.4 Implantable Ports
1.3.5 Intravenous Catheters
1.3.6 Hypodermic Needles
1.3.7 Other
1.4 Global Intravenous(IV) Therapy and Vein Access Market by Application
1.4.1 Overview: Global Intravenous(IV) Therapy and Vein Access Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinics
1.4.4 Other
1.5 Global Intravenous(IV) Therapy and Vein Access Market Size & Forecast
1.6 Global Intravenous(IV) Therapy and Vein Access Market Size and Forecast by Region
1.6.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Intravenous(IV) Therapy and Vein Access Market Size by Region, (2019-2030)
1.6.3 North America Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
1.6.4 Europe Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
1.6.6 South America Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Intravenous(IV) Therapy and Vein Access Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 B. Braun
2.1.1 B. Braun Details
2.1.2 B. Braun Major Business
2.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Product and Solutions
2.1.4 B. Braun Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 B. Braun Recent Developments and Future Plans
2.2 Baxter International
2.2.1 Baxter International Details
2.2.2 Baxter International Major Business
2.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Product and Solutions
2.2.4 Baxter International Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Baxter International Recent Developments and Future Plans
2.3 Becton Dickinson
2.3.1 Becton Dickinson Details
2.3.2 Becton Dickinson Major Business
2.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Product and Solutions
2.3.4 Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Becton Dickinson Recent Developments and Future Plans
2.4 C. R. Bard
2.4.1 C. R. Bard Details
2.4.2 C. R. Bard Major Business
2.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Product and Solutions
2.4.4 C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 C. R. Bard Recent Developments and Future Plans
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business
2.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Product and Solutions
2.5.4 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Fresenius Kabi Recent Developments and Future Plans
2.6 Hospira(ICU Medical)
2.6.1 Hospira(ICU Medical) Details
2.6.2 Hospira(ICU Medical) Major Business
2.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Product and Solutions
2.6.4 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Hospira(ICU Medical) Recent Developments and Future Plans
2.7 Medtronic
2.7.1 Medtronic Details
2.7.2 Medtronic Major Business
2.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Product and Solutions
2.7.4 Medtronic Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Medtronic Recent Developments and Future Plans
2.8 Smiths Group
2.8.1 Smiths Group Details
2.8.2 Smiths Group Major Business
2.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Product and Solutions
2.8.4 Smiths Group Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Smiths Group Recent Developments and Future Plans
2.9 Teleflex
2.9.1 Teleflex Details
2.9.2 Teleflex Major Business
2.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Product and Solutions
2.9.4 Teleflex Intravenous(IV) Therapy and Vein Access Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teleflex Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Intravenous(IV) Therapy and Vein Access Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Intravenous(IV) Therapy and Vein Access by Company Revenue
3.2.2 Top 3 Intravenous(IV) Therapy and Vein Access Players Market Share in 2023
3.2.3 Top 6 Intravenous(IV) Therapy and Vein Access Players Market Share in 2023
3.3 Intravenous(IV) Therapy and Vein Access Market: Overall Company Footprint Analysis
3.3.1 Intravenous(IV) Therapy and Vein Access Market: Region Footprint
3.3.2 Intravenous(IV) Therapy and Vein Access Market: Company Product Type Footprint
3.3.3 Intravenous(IV) Therapy and Vein Access Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Intravenous(IV) Therapy and Vein Access Consumption Value and Market Share by Type (2019-2024)
4.2 Global Intravenous(IV) Therapy and Vein Access Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2024)
5.2 Global Intravenous(IV) Therapy and Vein Access Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
6.2 North America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
6.3 North America Intravenous(IV) Therapy and Vein Access Market Size by Country
6.3.1 North America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2030)
6.3.2 United States Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
6.3.3 Canada Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
6.3.4 Mexico Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
7.2 Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
7.3 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country
7.3.1 Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2030)
7.3.2 Germany Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7.3.3 France Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7.3.5 Russia Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
7.3.6 Italy Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region
8.3.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2019-2030)
8.3.2 China Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.3 Japan Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.4 South Korea Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.5 India Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
8.3.7 Australia Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
9.2 South America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
9.3 South America Intravenous(IV) Therapy and Vein Access Market Size by Country
9.3.1 South America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2030)
9.3.2 Brazil Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
9.3.3 Argentina Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country
10.3.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2030)
10.3.2 Turkey Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
10.3.4 UAE Intravenous(IV) Therapy and Vein Access Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Intravenous(IV) Therapy and Vein Access Market Drivers
11.2 Intravenous(IV) Therapy and Vein Access Market Restraints
11.3 Intravenous(IV) Therapy and Vein Access Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Intravenous(IV) Therapy and Vein Access Industry Chain
12.2 Intravenous(IV) Therapy and Vein Access Upstream Analysis
12.3 Intravenous(IV) Therapy and Vein Access Midstream Analysis
12.4 Intravenous(IV) Therapy and Vein Access Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2025-2030) & (USD Million)
Table 5. B. Braun Company Information, Head Office, and Major Competitors
Table 6. B. Braun Major Business
Table 7. B. Braun Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 8. B. Braun Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. B. Braun Recent Developments and Future Plans
Table 10. Baxter International Company Information, Head Office, and Major Competitors
Table 11. Baxter International Major Business
Table 12. Baxter International Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 13. Baxter International Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Baxter International Recent Developments and Future Plans
Table 15. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 16. Becton Dickinson Major Business
Table 17. Becton Dickinson Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 18. Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Becton Dickinson Recent Developments and Future Plans
Table 20. C. R. Bard Company Information, Head Office, and Major Competitors
Table 21. C. R. Bard Major Business
Table 22. C. R. Bard Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 23. C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. C. R. Bard Recent Developments and Future Plans
Table 25. Fresenius Kabi Company Information, Head Office, and Major Competitors
Table 26. Fresenius Kabi Major Business
Table 27. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 28. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Fresenius Kabi Recent Developments and Future Plans
Table 30. Hospira(ICU Medical) Company Information, Head Office, and Major Competitors
Table 31. Hospira(ICU Medical) Major Business
Table 32. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 33. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Hospira(ICU Medical) Recent Developments and Future Plans
Table 35. Medtronic Company Information, Head Office, and Major Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 38. Medtronic Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Medtronic Recent Developments and Future Plans
Table 40. Smiths Group Company Information, Head Office, and Major Competitors
Table 41. Smiths Group Major Business
Table 42. Smiths Group Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 43. Smiths Group Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Smiths Group Recent Developments and Future Plans
Table 45. Teleflex Company Information, Head Office, and Major Competitors
Table 46. Teleflex Major Business
Table 47. Teleflex Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 48. Teleflex Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Teleflex Recent Developments and Future Plans
Table 50. Global Intravenous(IV) Therapy and Vein Access Revenue (USD Million) by Players (2019-2024)
Table 51. Global Intravenous(IV) Therapy and Vein Access Revenue Share by Players (2019-2024)
Table 52. Breakdown of Intravenous(IV) Therapy and Vein Access by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Intravenous(IV) Therapy and Vein Access, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Intravenous(IV) Therapy and Vein Access Players
Table 55. Intravenous(IV) Therapy and Vein Access Market: Company Product Type Footprint
Table 56. Intravenous(IV) Therapy and Vein Access Market: Company Product Application Footprint
Table 57. Intravenous(IV) Therapy and Vein Access New Market Entrants and Barriers to Market Entry
Table 58. Intravenous(IV) Therapy and Vein Access Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Intravenous(IV) Therapy and Vein Access Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Intravenous(IV) Therapy and Vein Access Consumption Value Share by Type (2019-2024)
Table 61. Global Intravenous(IV) Therapy and Vein Access Consumption Value Forecast by Type (2025-2030)
Table 62. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024)
Table 63. Global Intravenous(IV) Therapy and Vein Access Consumption Value Forecast by Application (2025-2030)
Table 64. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Intravenous(IV) Therapy and Vein Access Raw Material
Table 95. Key Suppliers of Intravenous(IV) Therapy and Vein Access Raw Materials
Table 1. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2025-2030) & (USD Million)
Table 5. B. Braun Company Information, Head Office, and Major Competitors
Table 6. B. Braun Major Business
Table 7. B. Braun Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 8. B. Braun Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. B. Braun Recent Developments and Future Plans
Table 10. Baxter International Company Information, Head Office, and Major Competitors
Table 11. Baxter International Major Business
Table 12. Baxter International Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 13. Baxter International Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Baxter International Recent Developments and Future Plans
Table 15. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 16. Becton Dickinson Major Business
Table 17. Becton Dickinson Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 18. Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Becton Dickinson Recent Developments and Future Plans
Table 20. C. R. Bard Company Information, Head Office, and Major Competitors
Table 21. C. R. Bard Major Business
Table 22. C. R. Bard Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 23. C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. C. R. Bard Recent Developments and Future Plans
Table 25. Fresenius Kabi Company Information, Head Office, and Major Competitors
Table 26. Fresenius Kabi Major Business
Table 27. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 28. Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Fresenius Kabi Recent Developments and Future Plans
Table 30. Hospira(ICU Medical) Company Information, Head Office, and Major Competitors
Table 31. Hospira(ICU Medical) Major Business
Table 32. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 33. Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Hospira(ICU Medical) Recent Developments and Future Plans
Table 35. Medtronic Company Information, Head Office, and Major Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 38. Medtronic Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Medtronic Recent Developments and Future Plans
Table 40. Smiths Group Company Information, Head Office, and Major Competitors
Table 41. Smiths Group Major Business
Table 42. Smiths Group Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 43. Smiths Group Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Smiths Group Recent Developments and Future Plans
Table 45. Teleflex Company Information, Head Office, and Major Competitors
Table 46. Teleflex Major Business
Table 47. Teleflex Intravenous(IV) Therapy and Vein Access Product and Solutions
Table 48. Teleflex Intravenous(IV) Therapy and Vein Access Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Teleflex Recent Developments and Future Plans
Table 50. Global Intravenous(IV) Therapy and Vein Access Revenue (USD Million) by Players (2019-2024)
Table 51. Global Intravenous(IV) Therapy and Vein Access Revenue Share by Players (2019-2024)
Table 52. Breakdown of Intravenous(IV) Therapy and Vein Access by Company Type (Tier 1, Tier 2, and Tier 3)
Table 53. Market Position of Players in Intravenous(IV) Therapy and Vein Access, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 54. Head Office of Key Intravenous(IV) Therapy and Vein Access Players
Table 55. Intravenous(IV) Therapy and Vein Access Market: Company Product Type Footprint
Table 56. Intravenous(IV) Therapy and Vein Access Market: Company Product Application Footprint
Table 57. Intravenous(IV) Therapy and Vein Access New Market Entrants and Barriers to Market Entry
Table 58. Intravenous(IV) Therapy and Vein Access Mergers, Acquisition, Agreements, and Collaborations
Table 59. Global Intravenous(IV) Therapy and Vein Access Consumption Value (USD Million) by Type (2019-2024)
Table 60. Global Intravenous(IV) Therapy and Vein Access Consumption Value Share by Type (2019-2024)
Table 61. Global Intravenous(IV) Therapy and Vein Access Consumption Value Forecast by Type (2025-2030)
Table 62. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024)
Table 63. Global Intravenous(IV) Therapy and Vein Access Consumption Value Forecast by Application (2025-2030)
Table 64. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 65. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 66. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 67. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 68. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2024) & (USD Million)
Table 69. North America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2025-2030) & (USD Million)
Table 70. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 73. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 74. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 77. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 78. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 79. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 80. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2019-2024) & (USD Million)
Table 81. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value by Region (2025-2030) & (USD Million)
Table 82. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 83. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 84. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 85. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 86. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2019-2024) & (USD Million)
Table 89. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Type (2025-2030) & (USD Million)
Table 90. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2019-2024) & (USD Million)
Table 91. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Application (2025-2030) & (USD Million)
Table 92. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2019-2024) & (USD Million)
Table 93. Middle East & Africa Intravenous(IV) Therapy and Vein Access Consumption Value by Country (2025-2030) & (USD Million)
Table 94. Intravenous(IV) Therapy and Vein Access Raw Material
Table 95. Key Suppliers of Intravenous(IV) Therapy and Vein Access Raw Materials
LIST OF FIGURES
Figure 1. Intravenous(IV) Therapy and Vein Access Picture
Figure 2. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type in 2023
Figure 4. Infusion Pumps
Figure 5. Implantable Ports
Figure 6. Intravenous Catheters
Figure 7. Hypodermic Needles
Figure 8. Other
Figure 9. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application in 2023
Figure 11. Hospital Picture
Figure 12. Clinics Picture
Figure 13. Other Picture
Figure 14. Global Intravenous(IV) Therapy and Vein Access Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Intravenous(IV) Therapy and Vein Access Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Intravenous(IV) Therapy and Vein Access Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Region in 2023
Figure 19. North America Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Intravenous(IV) Therapy and Vein Access Revenue Share by Players in 2023
Figure 25. Intravenous(IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Intravenous(IV) Therapy and Vein Access Market Share in 2023
Figure 27. Global Top 6 Players Intravenous(IV) Therapy and Vein Access Market Share in 2023
Figure 28. Global Intravenous(IV) Therapy and Vein Access Consumption Value Share by Type (2019-2024)
Figure 29. Global Intravenous(IV) Therapy and Vein Access Market Share Forecast by Type (2025-2030)
Figure 30. Global Intravenous(IV) Therapy and Vein Access Consumption Value Share by Application (2019-2024)
Figure 31. Global Intravenous(IV) Therapy and Vein Access Market Share Forecast by Application (2025-2030)
Figure 32. North America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 42. France Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Region (2019-2030)
Figure 49. China Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 52. India Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 66. Intravenous(IV) Therapy and Vein Access Market Drivers
Figure 67. Intravenous(IV) Therapy and Vein Access Market Restraints
Figure 68. Intravenous(IV) Therapy and Vein Access Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Intravenous(IV) Therapy and Vein Access in 2023
Figure 71. Manufacturing Process Analysis of Intravenous(IV) Therapy and Vein Access
Figure 72. Intravenous(IV) Therapy and Vein Access Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Intravenous(IV) Therapy and Vein Access Picture
Figure 2. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type in 2023
Figure 4. Infusion Pumps
Figure 5. Implantable Ports
Figure 6. Intravenous Catheters
Figure 7. Hypodermic Needles
Figure 8. Other
Figure 9. Global Intravenous(IV) Therapy and Vein Access Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application in 2023
Figure 11. Hospital Picture
Figure 12. Clinics Picture
Figure 13. Other Picture
Figure 14. Global Intravenous(IV) Therapy and Vein Access Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Intravenous(IV) Therapy and Vein Access Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Intravenous(IV) Therapy and Vein Access Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Region in 2023
Figure 19. North America Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Intravenous(IV) Therapy and Vein Access Revenue Share by Players in 2023
Figure 25. Intravenous(IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Intravenous(IV) Therapy and Vein Access Market Share in 2023
Figure 27. Global Top 6 Players Intravenous(IV) Therapy and Vein Access Market Share in 2023
Figure 28. Global Intravenous(IV) Therapy and Vein Access Consumption Value Share by Type (2019-2024)
Figure 29. Global Intravenous(IV) Therapy and Vein Access Market Share Forecast by Type (2025-2030)
Figure 30. Global Intravenous(IV) Therapy and Vein Access Consumption Value Share by Application (2019-2024)
Figure 31. Global Intravenous(IV) Therapy and Vein Access Market Share Forecast by Application (2025-2030)
Figure 32. North America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 42. France Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Region (2019-2030)
Figure 49. China Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 52. India Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Intravenous(IV) Therapy and Vein Access Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Intravenous(IV) Therapy and Vein Access Consumption Value (2019-2030) & (USD Million)
Figure 66. Intravenous(IV) Therapy and Vein Access Market Drivers
Figure 67. Intravenous(IV) Therapy and Vein Access Market Restraints
Figure 68. Intravenous(IV) Therapy and Vein Access Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Intravenous(IV) Therapy and Vein Access in 2023
Figure 71. Manufacturing Process Analysis of Intravenous(IV) Therapy and Vein Access
Figure 72. Intravenous(IV) Therapy and Vein Access Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source